Definitive Contract 75N91020C00012
Award Date
8/24/20
Potential Completion Date
9/15/21
Potential Value
$387K
Federal Agency
National Cancer Institute
Awardee
Reveal Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Reveal Biosciences Inc., a self-certified small disadvantaged business, for SBIR Phase I efforts on the topic of "Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring." The potential value of the contract is $392,343.00. Reveal Biosciences is a computational pathology company that...
This is a $370,804.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS), to Reveal Biosciences Inc. The contract is for the development of an image-based platform to comprehensively de-identify whole slide imaging (WSI) data for cancer research. This was a total small business set-aside contract. Reveal Biosciences is a computational...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This is a firm-fixed price purchase order contract awarded by the National Oceanic and Atmospheric Administration (NOAA), a civilian agency under the U.S. Department of Commerce, to Reveal Biosciences Inc., a self-certified small disadvantaged business. The contract, valued at $38,661.50, is for histology sampling services in support of research conducted by the National Marine Fisheries Service (NMFS), a line office within NOAA. The contract has a total small business set-aside designation,...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,515 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The single year contract runs from February 20, 2024 through February 19, 2025 and utilizes a firm fixed price payment structure. Performance will occur in Bethesda, Maryland. No additional details were provided regarding the original solicitation...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The $355,000 Firm Fixed Price contract was awarded to Insilicom LLC, a minority-owned and woman-owned small business, to develop a proof-of-concept technology for drug repurposing targeting rare cancers using a large-scale, high-quality biomedical knowledge graph. The original contract opportunity was a...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute, which is part of the Department of Health and Human Services' National Institutes of Health. The contract, valued at $397,457, is with Kitware Inc., a for-profit software company, to develop image de-identification capabilities or accelerate cancer research using advanced imaging techniques. The contract is set aside for small businesses. Kitware is known for providing open source...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...